Amgen is cutting 180 R&D jobs and exiting neuroscience R&D. Novartis receives a clinical hold. IVERIC up 57% YTD after phase 2 data. Looking for …

Link to Full Article: Read Here

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!